mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
mRNA |
NSC-87877 |
GDSC1000 |
pan-cancer |
AAC |
0.0032 |
0.9 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
0.0028 |
0.9 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |